Lundbeck gör miljardresultat

För 2009 redovisar läkemedelsbolaget ett resultat på över 3,5 miljarder och för 2010 är förväntningarna än högre.

Discovery of new role for leukemia gene

Martin Bergö and his colleagues have studied two gene variants that often occur in acute leukemias. One gene codes for the protein RAS, which accelerates cell d...

Industrifonden satsar på life science

Industrifonden har investerat 40 miljoner kronor i Index Pharmaceuticals. Det är deras tredje investering inom life science på kort tid.

Det vänder uppåt för Life Science

Ten recieve the Venture Cup West Prize

At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.

Biogaia's advance goes on

In December Biogaia reached China and North America. Now, the Swedish probiotic company has entered the Mexican market.

This is Sweden's largest life science region

About 60 percent of all jobs within swedish life science are found in the Stockholm-Uppsala area. This was stated in a report presented at Scanlab & Biotech Forum today.

DKK 1,3 billion for grand research

Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.

Future drugs from Amaryllis

A Danish research team has discovered possibolities to extract drugs fro Amaryllis.

Will the industry follow the economic revival?

Welcome to the eleventh Biotech Forum + Scanlab Fair!

New study of toxins and heart disease

Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study...

Biotech dippar i börskrisen

De senaste månaderna har varit minst sagt turbulenta på börsen. De stora bolagen står starka medan högriskbolag i tidiga forskningsfaser ligger en bra bit under index.

Danish biorefinery can save US billions

The Danish Inbicon biorefinery process could save the US billions on foreign oil, the organization states.

New tools to fight bacteria

Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...

Infidelity produces faster sperms

Until now, it has been difficult to prove that fast-swimming sperms have an advantage when it comes to fertilizing an egg.

Swedish nanotech crosses the Atlantic

Genovis signs distribution agreement Finnzymes in US.

Förklarar samband mellan melatonin och diabetes

Sömnhormonet melatonin försämrar insulinfrisättningen hos personer med en vanlig genvariant, visar en studie från Lunds universitet.

Success fee to Bioinvent and partner

The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.

Take off for this year's fair

More visitors than previously were preregistered when Scanlab and Biotech Forum opened today. But the future of the exhibitions and their design is uncertain.

Fortsatt fokus på kliniska studier

Diamyds förlust minskar och bolaget ser fram emot att presentera resultaten från sina kliniska prövningar.

Age essential when testing drugs

Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...

Preparering av sekvenseringsbibliotek från blod

Med Globin-Zero teknologin erhålls effektivare sekvenseringsbibliotek utan globin-mRNA eller ribosomalt rRNA.

High hopes for future partnering - the solution for struggling fairs

Business fairs are struggling but the concept of partnering is hotter than ever. By using social media, participants can prepare themselves for the perfect meeting.

First ever study of human stem cell treatment

The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.